Table 3 .
Secondary target parameters
| Secondary endpoints | TissuGlu number | percentage respective mean (SD) |
Control number | percentage respective mean (SD) |
|---|---|---|
| Output | ||
| Drainage in domo [ml] | – | 293 (174) |
| Drainage ex domo [ml] | – | 145 (169) |
| Aspiration [ml] | 514 (420) | 139 (311) |
| Total volume [ml] | 514 (420) | 577 (393) |
| Wound conditions | ||
| Seroma formation | 8 | 100% | 5 | 63% |
| Aspirations | 5.4 (3.4) | 1.7 (2.8) |
| Mean seroma size [cm] | 1.5 (0.5) | 1.7 (0.6) |
| Infection | 2 | 25% | 0 | 0% |
| Haematoma | 2 | 25% | 0 | 0% |
| Wound dehiscence | 2 | 25% | 0 | 0% |
| Time information [days] | ||
| Days until seroma development | 8.5 (3.9) | 19.8 (5.1) |
| Drain in situ | – | 12.6 (6.0) |
| Duration of in-patient stay | 3.5 (0.7) | 5.2 (3.3) |
| Days until adjuvant treatment | 37.7 (14.4) | 36.0 (10.9) |
| Unscheduled Visits (mean) | 3.9 (3.14) | 1.3 (1.60) |
| Number of unscheduled visits (Σ) | 31 | 77.5% | 9 | 22.5% |